Document is current
Any future updates will be listed below
-
Authors
Díaz López, José Manuel
Guerrero Jiménez, José Manuel https://orcid.org/0009-0003-4863-458X
Láinez Ramos-Bossini, Antonio Jesús https://orcid.org/0000-0002-0663-2856
García Cerezo, Marta https://orcid.org/0009-0009-0889-2035
Ortega Sánchez, Francisco Gabriel https://orcid.org/0000-0003-0563-2237
Alcázar Navarrete, Bernardino https://orcid.org/0000-0003-2356-9366
-
Funding
Funding for this research was provided by:
Instituto de Salud Carlos III (PI22/01275)
- License Information
-
More Information
Article History
Received: 4 December 2025
Accepted: 3 February 2026
First Online: 21 March 2026
Declarations
:
: Not applicable, as this study is a systematic review and meta-analysis based exclusively on previously published and publicly available data.
: The authors declare that no IA technology was used in the writing process.
: Not applicable.
: Not applicable.
: MGC has nothing to disclose. JMDL has nothing to disclose. AJLRB has nothing to disclose. JMGJ has nothing to disclose. FGOS has nothing to disclose. BAN declares conflicts of interest for having received consulting fees, research grants or lectures from AstraZeneca, Boehringer Ingelheim, Chiesi, CSL Behring, GSK, Laboratorios Bial, Laboratorios Menarini and Sanofi.
